Maldonado A - Search Results

1

Clinical Impact of 18F-FDG-PET in the Suspicion of Recurrent Ovarian Carcinoma Based on Elevated Tumor Marker Serum Levels.

Jiménez-Bonilla J, Maldonado A, Morales S, Salud A, Zomeño M, Román J, Belon J, Moya F. Jiménez-Bonilla J, et al. Among authors: maldonado a. Clin Positron Imaging. 2000 Nov;3(6):231-236. doi: 10.1016/s1095-0397(01)00053-x. Clin Positron Imaging. 2000. PMID: 11378435

2

Role of FDG-PET in the Diagnosis of Recurrent Medullary Thyroid Carcinoma Based on Rising Tumor Marker Levels.

Maldonado A, Peiró V V, Poveda A, Moya F, Trampal C, Ossola G, Ortega F, Ruiz JA, Gorospe E. Maldonado A, et al. Clin Positron Imaging. 1999 Nov;2(6):320. doi: 10.1016/s1095-0397(99)00080-1. Clin Positron Imaging. 1999. PMID: 14516617 No abstract available.

3

16. FDG-PET in the Detection of Recurrence in Colorectal Cancer Based on Rising CEA Level. Experience in 72 Patients.

Maldonado A, Sancho F, Cerdan J, Lozano A, Mohedano N, Jiménez J, Moya F, Zomeño M. Maldonado A, et al. Clin Positron Imaging. 2000 Jul;3(4):170. doi: 10.1016/s1095-0397(00)00082-0. Clin Positron Imaging. 2000. PMID: 11150773

4

17. Utility of Metabolic Imaging in Oral Squamous Cell Carcinoma (SCC) Staging. Experience in 30 Patients.

Moya F, Gómez F, De Pedro M, Maldonado A, Melgarejo M, Gorospe E, Ruiz J, Jiménez J, Pozo M. Moya F, et al. Among authors: maldonado a. Clin Positron Imaging. 2000 Jul;3(4):171. doi: 10.1016/s1095-0397(00)00083-2. Clin Positron Imaging. 2000. PMID: 11150774

5

FDG-PET in the Detection of Pleuro-peritoneal Malignant Disease with Negative Imaging Techniques.

Maldonado A, Ortega F, Pérez-Carrión R, de Uri;a C, Ruiz A, Moya F, Trampal C, Ossola G. Maldonado A, et al. Clin Positron Imaging. 1999 Nov;2(6):319. doi: 10.1016/s1095-0397(99)00079-5. Clin Positron Imaging. 1999. PMID: 14516616 No abstract available.

6

Value of FDG-PET in the Therapeutic Management of Recurrent Ovarian Cancer. Experience in 31 Patients.

Maldonado A, Sancho F, Perez-Carrión R, Señor C, Moya F, Trampal C, Ossola G, Ortega F, Melgarejo M. Maldonado A, et al. Clin Positron Imaging. 1999 Nov;2(6):321. doi: 10.1016/s1095-0397(99)00081-3. Clin Positron Imaging. 1999. PMID: 14516618 No abstract available.

7

[Role of the positron emission tomography (PET) in suspected tumor recurrence when there is increased serum tumor markers].

Trampal C, Maldonado A, Sancho Cuesta F, Morales S, Señor de Uría C, Panadés G, Ortega F. Trampal C, et al. Among authors: maldonado a. Rev Esp Med Nucl. 2000 Aug;19(4):279-87. Rev Esp Med Nucl. 2000. PMID: 11062099 Clinical Trial. Spanish.

8

19. Correlation between FDG PET data and EEG dipole modeling.

Pozo M, Pascau J, Rojo P, Maldonado A, Gonzalez F, Desco M, Sola R. Pozo M, et al. Among authors: maldonado a. Clin Positron Imaging. 2000 Jul;3(4):173. doi: 10.1016/s1095-0397(00)00085-6. Clin Positron Imaging. 2000. PMID: 11150776

9

The Role of FDG-PET in Diagnosing Suspected Tumor Recurrence Based on Increased Levels of Plasma Markers.

Maldonado A, Sancho F, Calvo FA, López N, Carrión RP, Barón MG, Trampal C, Ortega F. Maldonado A, et al. Clin Positron Imaging. 1998 Sep;1(4):246. doi: 10.1016/s1095-0397(98)00036-3. Clin Positron Imaging. 1998. PMID: 14516569 No abstract available.

10

PET-CT in clinical oncology.

Maldonado A, González-Alenda FJ, Alonso M, Sierra JM. Maldonado A, et al. Clin Transl Oncol. 2007 Aug;9(8):494-505. doi: 10.1007/s12094-007-0093-5. Clin Transl Oncol. 2007. PMID: 17720652 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters